COMP and ovarian carcinoma: Immunohistochemical analyses showed varying degrees of COMP expression in ovarian cancer tissues (Fig. 1A, B), with high COMP expression in the stroma being strongly associated with decreased OS of ovarian cancer patients (p < 0.001) (Fig. 1D).